Sun Pharma gets FDA green light for generic Ganirelix
Sun Pharmaceutical has received the Food and Drug Administration’s blessing for a generic version of Organon’s Ganirelix acetate injection 250 mcg/0.5 mL.
Ganirelix is an injectable competitive gonadotropin-releasing hormone antagonist, or GnRH antagonist.
The medication is primarily used in assisted reproduction to control ovulation.
The product had a market value of approximately $67 million for the 12 months ended September 2018, according to IQVIA.
Ganirelix is an injectable competitive gonadotropin-releasing hormone antagonist, or GnRH antagonist.
The medication is primarily used in assisted reproduction to control ovulation.
The product had a market value of approximately $67 million for the 12 months ended September 2018, according to IQVIA.